Heart Failure New York Heart Association Class III
2 clinical trials · Condition
◉ Watch Heart Failure New York Heart Association Class III
| Record | Firm | Date |
|---|---|---|
| Levosimendan In Ambulatory Heart Failure Patients (NCT04705337) | Medical University of Bialystok | 2021-12-15 |
Track Heart Failure New York Heart Association Class III automatically
Every clearance here is in the API, with alerts when new ones post.